TABLE 3.
OUTCOME: Visit 3 NT-Pro BNP (pg/ml) | ||||||||
---|---|---|---|---|---|---|---|---|
Adipokine | Model 1 | Model 2 | Model 3* | |||||
Estimate | p-value | Estimate | p-value | Estimate | p-value | |||
Adiponectin (1-SD) | 21.16 | < 0.01 | 21.0 | < 0.01 | 14.0 | < 0.01 | ||
Adiponectin Quartiles | ||||||||
-Q2* | 1.16 | 0.03 | 1.16 | 0.06 | 1.15 | 0.09 | ||
-Q3* | 1.40 | <0.01 | 1.41 | <0.01 | 1.42 | <0.01 | ||
-Q4* | 1.74 | <0.01 | 1.65 | <0.01 | 1.58 | <0.01 | ||
OUTCOME: NT-Pro BNP Change from Visit 1 to Visit 3 (pg/ml) | ||||||||
Adipokine | Model 1 | Model 2 | Model 3 | Model 4** | ||||
Estimate | p-value | Estimate | p-value | Estimate | p-value | Estimate | p-value | |
Adiponectin (1-SD) | 16.9 | < 0.01 | 16.3 | < 0.01 | 19.8 | < 0.01 | 23.9 | < 0.01 |
Adiponectin Quartiles | ||||||||
-Q2 | −7.9 | 0.55 | −15.0 | 0.35 | −7.7 | 0.65 | −5.0 | 0.77 |
-Q3 | 13.1 | 0.34 | 14.8 | 0.37 | 13.9 | 0.43 | 18.9 | 0.27 |
-Q4 | 34.4 | 0.02 | 27.6 | 0.13 | 31.9 | 0.11 | 43.0 | 0.03 |
1-SD = 1-standard deviation increment of total adiponectin (13.1 μg/ml), Parameter estimate is a percent (i.e. 1.16 = 16% higher than reference)
R2 (1-SD) = 0.36, R2 (Quartiles) = 0.37;
R2 = 0.09, R2 = 0.09
Model 1: age, sex and race
Model 2: Model 1 + height, visceral and subcutaneous fat areas, dyslipidemia, diabetes, smoking, hypertension, eGFR, leptin, aldosterone & renin
Model 3: Model 2 + left ventricular mass and left ventricular ejection fraction
Model 4: Model 3 + NT-proBNP (visit 1 value)